Joe Bonaccorso - Net Worth and Insider Trading
Joe Bonaccorso Net Worth
The estimated net worth of Joe Bonaccorso is at least $627,342 dollars as of 2024-04-23. Joe Bonaccorso is the Chief Commercial Officer of Verrica Pharmaceuticals Inc and owns about 92,392 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $627,342. Details can be seen in Joe Bonaccorso's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joe Bonaccorso has not made any transactions after 2023-11-15 and currently still holds the listed stock(s).
Transaction Summary of Joe Bonaccorso
Joe Bonaccorso Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joe Bonaccorso owns 1 companies in total, including Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Joe Bonaccorso’s form 4 insider trades.
Insider Ownership Summary of Joe Bonaccorso
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2023-11-15 | Chief Commercial Officer |
Joe Bonaccorso Latest Holdings Summary
Joe Bonaccorso currently owns a total of 1 stock. Joe Bonaccorso owns 92,392 shares of Verrica Pharmaceuticals Inc (VRCA) as of November 15, 2023, with a value of $627,342.
Latest Holdings of Joe Bonaccorso
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2023-11-15 | 92,392 | 6.79 | 627,342 |
Holding Weightings of Joe Bonaccorso
Joe Bonaccorso Form 4 Trading Tracker
According to the SEC Form 4 filings, Joe Bonaccorso has made a total of 2 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the sale of 32,846 shares on November 15, 2023, which brought Joe Bonaccorso around $96,567.
Insider Trading History of Joe Bonaccorso
- 1
Joe Bonaccorso Trading Performance
GuruFocus tracks the stock performance after each of Joe Bonaccorso's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joe Bonaccorso is -12.11%. GuruFocus also compares Joe Bonaccorso's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joe Bonaccorso within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joe Bonaccorso's insider trading performs compared to the benchmark.
Performance of Joe Bonaccorso
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.83 | -12.11 | -56.67 | -53.96 | -16.04 | -16.07 |
| Relative Return to S&P 500(%) | -7.35 | -17.37 | -47.42 | -59.89 | -21.92 | -30.75 |
Joe Bonaccorso Ownership Network
Ownership Network List of Joe Bonaccorso
Ownership Network Relation of Joe Bonaccorso
Joe Bonaccorso Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Joe Bonaccorso is the Chief Commercial Officer of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and General Counsel Christopher G. Hayes .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Joe Bonaccorso made 2 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net sale of 71,108. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 67,488 shares made by Christopher G. Hayes .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
Joe Bonaccorso Mailing Address
Above is the net worth, insider trading, and ownership report for Joe Bonaccorso. You might contact Joe Bonaccorso via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
